... after recurrence demonstrated that some patients treated with cisplatin/vincristine/fluorouracil could be salvaged with doxorubicin-containing regimens, but patients treated with doxorubicin/cisplatin could not ...

... 70 ] Alkylating agents. - Cyclophosphamide. Fluoropyrimidines. - Capecitabine.[ 71 - 73 ] ... - Ixabepilone.[ 78 ] Combination regimens that have shown activity in metastatic breast cancer ...

... of adenocarcinoma of unknown primary with a 5-fluorouracil-cisplatin chemotherapy regimen (CFTam). Annals of Oncology. 1999; 10 (11):1389– ... of adenocarcinoma of unknown primary with a 5-fluorouracil-cisplatin chemotherapy regimen (CFTam). Annals of Oncology. 1999; 10 (11):1389– ...

... clinical benefit, although patients are often treated with regimens used to treat cervical cancer. Concurrent chemotherapy, using fluorouracil or cisplatin-based therapy, and radiation are sometimes advocated, based ...

... methotrexate with folinic acid rescue, dactinomycin, cyclophosphamide, and vincristine. This appears to be the most commonly used regimen. EP/EMA: Etoposide and cisplatin with etoposide, methotrexate, and dactinomycin. MAE: Methotrexate with ...

... mg given each day of a 5-day cisplatin regimen provides additional antiemetic benefit, and it may add ... has been studied in patients receiving 5-day cisplatin regimens.[ 12 , 13 ] Standard antiemetic prophylaxis includes a 5- ...